Janssen reveals new long-term data in Crohn’s disease at ECCO 2017
Janssen is looking forward to sharing its latest research at the 12th Congress of the European Crohn’s and Colitis Organisation (ECCO) which will be taking place in Barcelona, Spain from 15–18 February. The ECCO Congress is a key educational event for the Inflammatory Bowel Disease (IBD) community. More than 5,000 scientific and medical experts, including gastroenterologists and nurses, will come together from around the world to learn about the latest research and clinical care in IBD and a record number of abstracts will be presented this year.
Janssen will be hosting a symposium entitled ‘Raising the bar: Defining the new era of Crohn’s disease management’ on Friday, 17 February. Chaired by Professor Subrata Ghosh, the symposium will focus on understanding unmet patient needs and how to overcome them in the clinic; long-term management of Crohn’s disease and current and emerging therapies in the field.
Janssen is committed to continuing research into immune and inflammatory diseases to help improve outcomes and the quality of life for people with IBD.
- European Federation of Pharmaceutical Industries and Associations. Inflammatory Bowel Disease. Available at http://www.efpia.eu/diseases/78/59/Inflammatory-Bowel-Disease. Last accessed January 2017.
- Janssen EU Disease Lens. 2015. Crohn’s disease. Available at http://www.diseaselens.com/v2/disease.php?disease=1#. Last accessed January 2017.
- Centres for Disease Control and Prevention. Inflammatory bowel disease (IBD). Available at http://www.cdc.gov/ibd/what-is-ibd.htm. Last accessed January 2017.